Cargando…
A Nanopore sequencing-based pharmacogenomic panel to personalize tuberculosis drug dosing
RATIONALE: Standardized dosing of anti-tubercular (TB) drugs leads to variable plasma drug levels, which are associated with adverse drug reactions, delayed treatment response, and relapse. Mutations in genes affecting drug metabolism explain considerable interindividual pharmacokinetic variability;...
Autores principales: | Verma, Renu, da Silva, Kesia Esther, Rockwood, Neesha, Wasmann, Roeland E., Yende, Nombuso, Song, Taeksun, Kim, Eugene, Denti, Paolo, Wilkinson, Robert. J., Andrews, Jason R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10508808/ https://www.ncbi.nlm.nih.gov/pubmed/37732197 http://dx.doi.org/10.1101/2023.09.08.23295248 |
Ejemplares similares
-
HIV-1 Coinfection Does Not Reduce Exposure to Rifampin, Isoniazid, and Pyrazinamide in South African Tuberculosis Outpatients
por: Rockwood, Neesha, et al.
Publicado: (2016) -
Concentration-Dependent Antagonism and Culture Conversion in Pulmonary Tuberculosis
por: Rockwood, Neesha, et al.
Publicado: (2017) -
Low Frequency of Acquired Isoniazid and Rifampicin Resistance in Rifampicin-Susceptible Pulmonary Tuberculosis in a Setting of High HIV-1 Infection and Tuberculosis Coprevalence
por: Rockwood, Neesha, et al.
Publicado: (2017) -
Constructing a representative in‐silico population for paediatric simulations: Application to HIV‐positive African children
por: Wasmann, Roeland E., et al.
Publicado: (2021) -
Pharmacogenomics and Personalized Medicine
por: Cecchin, Erika, et al.
Publicado: (2020)